Hepatic involvement in hereditary hemorrhagic telangiectasia: An unusual indication for liver transplantation
โ Scribed by Christian Hillert; Dieter C. Broering; Matthias Gundlach; Wolfram T. Knoefel; Jakob R. Izbicki; Xavier Rogiers
- Book ID
- 111722974
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 190 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1527-6465
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by mucocutaneous and visceral telangiectasia. Hepatic involvement with vascular malformations may lead to portal hypertension, biliary ischemia, and high-output cardiac failure. Liver transplantation is indica
unclear, and further experience in a clinical trial setting is required to clarify this. Lastly, it is exciting to ponder that vascular endothelial growth factor antagonists may have a role in reducing symptoms in the substantial number of HHT patients who are symptomatic but do not require liver tr
Liver involvement in hereditary hemorrhagic telangiectasia may lead to high-output cardiac failure. Few data have been reported on orthotopic liver transplantation (OLT) for these patients. In this paper, we describe two patients treated by OLT as a salvage procedure for cardiac failure, and we revi